Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-content site release or build change rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check34 days agoChange DetectedPadua, Italy was updated to Padova, Italy in the locations section.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded 'Gastrointestinal stromal tumor' as a disease term and a Resources section linking Genetic and Rare Diseases Information Center to the page.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The previous revision is no longer active.SummaryDifference0.0%

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.